NEUROENDOCRINE TUMORS
Clinical trials for NEUROENDOCRINE TUMORS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMORS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive drug tested to stop Cancer's return after liver surgery
Disease control TerminatedThis study tested whether giving Lutathera, a targeted radioactive drug, after surgery to remove neuroendocrine tumor spread in the liver could prevent the cancer from coming back. It compared this treatment against standard monitoring and supportive care in patients whose primar…
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Experimental pill tested for Tough-to-Treat gut tumors
Disease control TerminatedThis study tested an oral medication called entinostat for people with advanced abdominal neuroendocrine tumors that had returned or stopped responding to standard treatments. The goal was to see if the weekly pill could shrink tumors or slow their growth. The trial was small and…
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC